Canada markets close in 4 hours 9 minutes

Ionis Pharmaceuticals, Inc. (IONS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
25.95-0.20 (-0.76%)
As of 11:51AM EST. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.88B
Enterprise Value 3.20B
Trailing P/E 114.71
Forward P/E 90.91
PEG Ratio (5 yr expected) 25.70
Price/Sales (ttm)5.85
Price/Book (mrq)7.31
Enterprise Value/Revenue 4.84
Enterprise Value/EBITDA -13.32

Trading Information

Stock Price History

Beta (5Y Monthly) 0.99
52-Week Change 3-48.95%
S&P500 52-Week Change 323.73%
52 Week High 364.37
52 Week Low 325.04
50-Day Moving Average 332.24
200-Day Moving Average 338.86

Share Statistics

Avg Vol (3 month) 31.04M
Avg Vol (10 day) 31.33M
Shares Outstanding 5141.21M
Implied Shares Outstanding 6N/A
Float 8140M
% Held by Insiders 10.81%
% Held by Institutions 186.94%
Shares Short (Nov. 14, 2021) 46.19M
Short Ratio (Nov. 14, 2021) 45.63
Short % of Float (Nov. 14, 2021) 45.19%
Short % of Shares Outstanding (Nov. 14, 2021) 44.38%
Shares Short (prior month Oct. 14, 2021) 46.78M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021


Profit Margin -93.04%
Operating Margin (ttm)-33.19%

Management Effectiveness

Return on Assets (ttm)-4.98%
Return on Equity (ttm)-57.64%

Income Statement

Revenue (ttm)660.73M
Revenue Per Share (ttm)4.70
Quarterly Revenue Growth (yoy)-16.90%
Gross Profit (ttm)182.24M
EBITDA -201.71M
Net Income Avi to Common (ttm)-614.97M
Diluted EPS (ttm)-4.37
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2B
Total Cash Per Share (mrq)14.16
Total Debt (mrq)1.31B
Total Debt/Equity (mrq)246.85
Current Ratio (mrq)7.70
Book Value Per Share (mrq)3.76

Cash Flow Statement

Operating Cash Flow (ttm)-74.91M
Levered Free Cash Flow (ttm)86.96M